You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Warren Stern

Founder at HO2.1 Annex Fund LP
Overview
Relationships
Paths
Education
Career History
Transactions

Warren Stern

Founder at HO2.1 Annex Fund LP

Overview

Age
72 (Born 1945)
Notable Companies
HO2.1 Annex Fund LP

Research Triangle Pharmaceuticals LLC
Number of Relationships
This person is connected to 506 people.

Relationships See Details


Senior Vice President-Biometrics & Regulatory at vTv Therapeutics, Inc.

Director of Clinical Pharmacology at Thomas Jefferson University Hospital

Consulting Pediatrician at Duke University Hospital

Co-Founder & General Partner at HO2 Partners

Co-Founder at HO2 Partners

Co-Founder at Origin Ventures

Senior Program Officer at The Burroughs Wellcome Fund

Senior Programs Assistant & Data Specialist at The Burroughs Wellcome Fund

Senior Program Associate & Database Specialist at The Burroughs Wellcome Fund

Program Officer at The Burroughs Wellcome Fund
See 496 more listings with RelSci Professional.

Paths to Warren Stern

Warren Stern
You
Connections via Relationship Science
Warren Stern
Sync your contacts to see how you can connect with Warren Stern.

Educational Background

 
Class of 1969 
Indiana University is a major multi-campus public research institution, grounded in the liberal arts and sciences, and a world leader in professional, medical, and technological education. Indiana University’s mission is to provide broad access to undergraduate, graduate, and continuing education for students throughout Indiana, the United States, and the world, as well as outstanding academic and cultural programs and student services. Indiana University seeks to create dynamic partnerships with the state and local communities in economic, social, and cultural development and to offer leadership in creative solutions for 21st century problems. Indiana University strives to achieve full diversity, and to maintain friendly, collegial, and humane environments, with a strong commitment to academic freedom.

Career History

Founder
Current
Founder
Prior - 2011
Senior Vice President-Drug Development
2003 - Prior
DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ.
Senior Vice President-Scientific & Medical Services
Prior
The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. BWF’s financial support is channeled primarily through competitive peer-reviewed award programs. BWF makes grants primarily to degree-granting institutions on behalf of individual researchers, who must be nominated by their institutions. To complement these competitive award programs, BWF also makes grants to nonprofit organizations conducting activities intended to improve the general environment for science.
Senior Vice President-Scientific & Medical Services
Prior
PAREXEL International Corp. engages in the provision of biopharmaceutical outsourcing services. It operates through the following segments: Clinical Research Services, PAREXEL Consulting, and PAREXEL Informatics. The Clinical Research Services segment includes clinical trials management and biostatistics, data management and clinical pharmacology, as well as related medical advisory, patient recruitment, clinical supply and drug logistics, pharmacoviligance, and investigator site services. The PAREXEL Consulting segment focuses on technical expertise and advice in such areas as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance. The PAREXEL Informatics segment offers information technology solutions designed to help improve client's product development, and regulatory submission processes. The company was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.
Senior Vice President-Scientific & Medical Services
Prior
Cato Research is a contract research and development organization that helps pharmaceutical and biotechnology companies design and execute successful development strategies. Cato provides their clients with a cost-effective alternative to building an internal structure for research and development. The company was founded by Dr. Allen Cato and Lynda Sutton in 1998.
Senior Vice President-Scientific & Medical Services
Prior
Senior Vice President-Scientific & Medical Services
Prior
Forest has well-established franchises in multiple therapeutic areas, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include Bystolic® (nebivolol), Daliresp® (roflumilast), Lexapro® (escitalopram oxalate), Linzess™ (linaclotide), Namenda® (memantine HCl), Savella®(milnacipran HCl), Teflaro® (ceftaroline fosamil) for injection, Tudorza™ Pressair™ (aclidinium bromide inhalation powder), and Viibryd® (vilazodone HCl). Forest identifies, develops, and delivers pharmaceutical products that make a difference in people's lives. We have been extremely successful in meeting our business objectives and expanding our franchises, but we also derive satisfaction in helping to bring relief to people who are suffering. We credit our success to our innovation, integrity, and commitment to developing important products
Clinical Consultant
Prior
QRxPharma Ltd. engages in the development and commercialization of biopharmaceutical products. Its products include pain management and abuse prevention products. The company was founded by Pace W. Gary, Michael Anthony Quinn and Felix de la Iglesia on September 19, 2002 and is headquartered in Sydney, Australia.

Transactions

Details Hidden
QRxPharma Ltd. raised money in a private placement transaction

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.